Comparison of laboratory detection methods of aspirin resistance in coronary artery disease patients

International Journal of Laboratory Hematology

Volumn 32, Issue 1 PART.2, 2010, Pages 50-55

  Kim, K E ^a   Woo, K S ^a   Goh, R Y ^a   Quan, M L ^a   Cha, K S ^a   Kim, M H ^a   Han, J Y ^a  

^a Dong A University College of Medicine   (South Korea)

Author keywords

Antiplatelet drug; Aspirin resistance; Coronary artery diseases; Platelet aggregation; Point of care testing

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ADULT; AGED; ARTICLE; BLOOD CLOTTING PARAMETERS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE COURSE; DRUG RESISTANCE; FEMALE; HEART INFARCTION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PLATELET AGGREGOMETRY; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY ANALYSIS; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; CORONARY ARTERY DISEASE; DRUG RESISTANCE; FEMALE; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; TICLOPIDINE;

EID: 77449091068     PISSN: 17515521     EISSN: 1751553X     Source Type: Journal    
DOI: 10.1111/j.1751-553X.2008.01119.x     Document Type: Article

References (17)

1. Chen W.H., Cheng X., Lee P.Y., Ng W., Kwok J.Y., Tse H.F. & Lau C.P. (2007) Aspirin resistance and adverse clinical events in patients with coronary artery disease. The American Journal of Medicine 120, 631-635.
2. Coleman J.L., Wang J.C. & Simon D.I. (2004) Determination of individual response to aspirin therapy using the Accumetrics Ultegra RPFA-ASA system. Point of Care 3, 77-82.
3. De Gaetano G. & Cerletti C. (2007) Platelet function, antiplatelet therapy and clinical outcomes: to test or not to test? Journal of Thrombosis and Haemostasis 5, 1835-1838.
4. Dichiara J., Bliden K.P., Tantry U.S., Chaganti S.K., Kreutz R.P., Gesheff T.B., Geshefe T.A., Kreutz Y. & Gurbel P.A. (2007) Platelet function measured by VerifyNow identifies generalized high platelet reactivity in aspirin treated patients. Platelets 18, 414-423.
5. Dorsch M.P., Lee J.S., Lynch D.R., Dunn S.P., Rodgers J.E., Schwartz T., Colby E., Montague D. & Smyth S.S. (2007) Aspirin resistance in patients with stable coronary artery disease with and without a history of myocardial infarction. The Annals of Pharmacotherapy 41, 737-741.
6. Fontana P., Nolli S., Reber G. & De Moerloose P. (2006) Biological effects of aspirin and clopidogrel in a randomized cross-over study in 96 healthy volunteers. Journal of Thrombosis and Haemostasis 4, 813-819.
7. Gum P.A., Kottke-Marchant K., Welsh P.A., White J. & Topol E.J. (2003) A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease. Journal of the American College of Cardiology 41, 961-965. (Pubitemid 36315537)
8. Gurbel P.A., Bliden K.P., DiChiara J., Newcomer J., Weng W., Neerchal N.K., Gesheff T., Chaganti S.K., Etherington A. & Tantry U.S. (2007) Evaluation of dose-related effects of aspirin on platelet function: results from the aspirininduced platelet effect (ASPECT) study. Circulation 115, 3156-3164. (Pubitemid 47012230)
9. Hankey G.J. & Eikelboom J.W. (2006) Aspirin resistance. Lancet 367, 606-617.
10. Krasopoulos G., Brister S.J., Beattie W.S. & Buchanan M.R. (2008) Aspirin "resistance" and risk of cardiovascular morbidity: systematic review and metaanalysis. British Medical Journal 336, 195-198.
11. Madsen E.H., Schmidt E.B., Gehr N., Johannesen N.L. & Kristensen S.R. (2008) Testing aspirin resistance using the platelet function analyzer-100: some methodological caveats and considerations. Journal of Thrombosis and Haemostasis 6, 386-388.
12. Michelson A.D. (2007) Monitoring antiplatelet therapy. Sysmex Journal International 17, 31-36.
13. Michelson A.D., Cattaneo M., Eikelboom J.W., Gurbel P., Kottke-Marchant K., Kunicki T.J., Pulcinelli F.M., Cerletti C., Rao A.K. & Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. (2005) Aspirin resistance: position paper of the working group on aspirin resistance. Journal of Thrombosis and Haemostasis 3, 1309-1311.
14. Paniccia R., Antonucci E., Gori A.M., Marcucci R., Poli S., Romano E., Valente S., Giglioli C., Fedi S., Gensini G.F., Abbate R. & Prisco D. (2007) Comparison of different methods to evaluate the effect of aspirin on platelet function in high-risk patients with ischemic heart disease receiving dual antiplatelet treatment. American Journal of Clinical Pathology 128, 143-149.
15. Snoep J.D., Hovens M.M., Eikelboom J.C., van der Bom J.G. & Huisman M.V. (2007) Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events: a systematic review and meta-analysis. Archives of Internal Medicine 167, 1593-1599.
16. Tseeng S. & Arora R. (2008) Aspirin resistance: biological and clinical implications. Journal of Cardiovascular Pharmacology and Therapeutics 13, 5-12.
17. Wang T.H., Bhatt D.L. & Topol E.J. (2006) Aspirin and clopidogrel resistance: an emerging clinical entity. European Heart Journal 27, 647-654.